BCM
CERE

BCK Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

BCK Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,000
Closed -$900K – 93
2024
Q2 		$900K Hold
22,000
– – 0.58% 41
2024
Q1 		$930K Hold
22,000
– – 0.63% 36
2023
Q4 		$933K Buy
+22,000
New +$933K 0.91% 34